Front > HEALTHCARE

HEALTHCARE

Nym Health team credit: Hagar Badar Israeli medical coding solutions co Nym raises $47m

Nym has automated the entire US healthcare medical coding process to deliver a faster, more cost-effective solution that outperforms traditional manual coding.

Immunai CEO Noam Solomon  credit: Immunai Israel's Immunai expands strategic tie with AstraZeneca

The agreement is worth an initial $18 million to Immunai, developer of an AI-based model for making drug development more efficient.

Teva's R&D labs in Netanya  credit: Teva PR Teva settles opioid suits in Israel

Under the settlement, Teva's insurance company, which as far as is known is not Israeli, will pay the pharmaceutical company $40 million to fully close all potential claims.

Dr. Shimon Eckhouse  credit: Tomer Shalom FDA approval boosts weight loss pill co Epitomee

Epitomee's product expands in the stomach, giving a sense of satiety. The big challenge now will be marketing.

Discure CEO Yuval Mandelbaum credit: Discure Bioelectronic implantable device co Discure raises $16m

The Israeli company has developed a device for the treatment of degenerative disc diseaseõ

Level Ex founder and CEO Sam Glassenberg credit: Level Ex "Israel can be in the forefront of medical gaming"

Level Ex founder and CEO Sam Glassenberg tells "Globes" about the growing industry of medical video games and apps to train and improve the performance of doctors.

Healthcare credit: Tali Bogdanovsky, Shlomi Yosef Chemomab jumps on positive liver scarring trial results

Chemomab Therapeutics is developing a treatment for rare liver scarring disease PSC.

Johnson & Johnson credit: PR Johnson & Johnson buys Israeli co V-Wave for up to $1.7b

V-Wave’s shunt is an implantable device designed to decrease elevated left atrial pressure seen in congestive heart failure.

DatTwo app credit: DayTwo Microbiome personalized health co DayTwo shuts down

Ultimately the Israeli company’s platform was not distinct enough from other nutritional menus.

Richard Francis  credit: PR Teva reports strong Q2 results, raises 2024 forecast

Teva CEO: We are also showing significant progress in on our late-stage innovative pipeline.

MedicannX aeroponic cultivation of cannabis credit: MedicannX Medical cannabis co MedicannX raises NIS 70m

The company is investing in a production plant in Tirat Hacarmel, using innovative aeroponic cultivation technology.

Heart surgery credit: Shutterstock Israeli heart pump co Magenta Medical raises $105m

The company has developed a miniature heart pump that can be inserted into the body through minimally invasive surgery.

CytoReason cofounder and CEO David Harel credit: Geva Talmor Israeli AI disease models co CytoReason raises $80m

Six of the world’s top 10 pharma companies use CytoReason’s technology to make data-driven decisions in immunology, inflammation, immuno-oncology, metabolism, and other therapeutic areas.

Pof. Ehud Raanani   credit: Sheba Medical Center The heart surgeon with a $300m exit: We had glitches

The sale to Edwards Lifesciences vindicates Innovalve's solution for the most common, and most challenging, heart valve disorder, and also Sheba Hospital's innovation model.

Ofer Gonen credit: Eran Lavi MediWound raises $25m, acquisition still possible

Swedish company Mölnlycke Health Care, an international leader in the field of treating wounds, led the private placement.

Prof. Ehud Raanani credit: Sheba Edwards Lifesciences buys Israeli co Innovalve Bio Medical

Sources estimate that Edwards will pay more than $300 million for Innovalve's trans-catheter mitral valve replacement device.

Yuval Soiref (far left) Mike Tyson (center) credit: Moses801 Yuval Soiref to market Mike Tyson medical cannabis in Germany

The Israeli businessman's long term aim is to build Phcann in the medical cannabis market in Europe including the UK, as well as in Australia.

Ofer Gonen credit: Eran Lavi MediWound jumps on reports of $400m bid by Solventum

The Israeli company has developed a pineapple-plant based product for treatment of burns and wounds.

Daria Lemann-Blumenthal credit: Tim Kerr Alcon completes acquisition of Israeli co Belkin Vision

Alcon will make an immediate payment of $81 million and a further $385 million in milestone payments, according to the product's success on the market.

Digital medicine credit: Shutterstock AI care co K Health raises $50m at $900m valuation

K Health CEO Allon Bloch: K Health solves the need to make primary care visits highly personalized by giving doctors AI super powers that enable them to practice at the top of their license.

Teva CEO Richard Francis  credit: Teva spokesperson US competition watchdog probing Teva's inhaler patents - report

According to "The Washington Post", the Federal Trade Commission is investigating whether Teva and other companies are using slight changes to products to extend patents.

Google offices Mountain View, California Photo: Shutterstock achinthamb Alphabet closing Verily health data Israel R&D center

Verily Life Sciences has 25 employees in Tel Aviv and Haifa.

Teva executive VP of global R&D and chief medical officer Dr. Eric A. Hughes  credit: Teva Teva exec reveals the AI tools pharma really wants

Fantasies of an AI revolution in drugs have met the reality of the industry's conservatism. But Teva’s head of R&D offers a glimpse into the AI tools his company actually uses, and is looking for. Startups take note.

Sensi.AI founders credit: Omer Hacohen Israeli care intelligence co Sensi.AI raises $31m

Sensi.AI's advanced audio platform detects and predicts care events while ensuring privacy during home care.

Teva  credit: Cineberg/Shutterstock Teva agrees $750m Israel Tax Authority settlement

The deal resolves all pending litigation on taxes payable by the company for 2008-2020.

Everyone wants a medical school  credit: Tali Bogdanovsky/Shutterstock Will rash of new medical schools solve Israel's doctor shortage?

Four new medical schools are planned in the coming years, but the government is not even aiming to reach the OECD average of doctors per thousand population.

Maurice Ferre illustration Gil Gibli Israeli ultrasound co Insightec raises $150m

The new financing comes several months after Insightec announced layoffs and a going concern qualification was attached to its financial results.

Medical research  credit: Shutterstock Clinical trials in Israel decline sharply

Revenue from trials by international companies in Israeli hospitals fell to NIS 518 million in 2023 from NIS 818 million in 2022.

Teva CEO Richard Francis  credit: Teva spokesperson Teva again king of Tel Aviv castle

After a 130% rise in its share price in the last year, the pharmaceuticals company has left the big two banks and Nice a long way behind.

Yanay Ofran credit: Eyal Izhar Biolojic Design signs Merck deal worth up to €346m

The Israeli biotech company uses AI and computerized biology to develop smart antibodies.

Twitter Facebook Linkedin RSS Newsletters âìåáñ Israel Business Conference 2018